Sign in to view content

The Functional Burden of Diabetic Retinopathy in the United States – How Ranibizumab May Shift Treatment Paradigms

Jeffrey R Willis, MD/PhD

Video
Published 2017

Related

Evaluation of Prevalence and Risk for Vitreoretinal Involvement in Fungemic Patients at a Tertiary Care Hospital
Carl S Wilkins, MD
Annual Meeting Talks
2021
Anti-VEGF treatment switch in DME and nAMD: a comparison of aflibercept versus ranibizumab after a single-dose switch
Estephania Feria, MD
On Demand Cases, Courses, and Papers
2019
Progression of diabetic retinopathy in patients treated with 0.2 μg/day
Raymond Iezzi, MD, MS
Updates from the Field
2017

Category: Diabetic Retinopathy

See more